0001209191-12-042188.txt : 20120816 0001209191-12-042188.hdr.sgml : 20120816 20120816162623 ACCESSION NUMBER: 0001209191-12-042188 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120814 FILED AS OF DATE: 20120816 DATE AS OF CHANGE: 20120816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaPlaca Anthony CENTRAL INDEX KEY: 0001453022 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 121040309 MAIL ADDRESS: STREET 1: ONE INVACARE WAY CITY: ELYRIA STATE: OH ZIP: 44035 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2012-08-14 0 0000742112 INVACARE CORP IVC 0001453022 LaPlaca Anthony ONE INVACARE WAY ELYRIA OH 44035 0 1 0 0 Sr. VP and General Counsel Common Shares 2012-08-14 4 A 0 3000 0.00 A 15368 D Employee Stock Option (Right to Buy) 13.37 2012-08-14 4 A 0 3375 0.00 A 2013-09-30 2022-08-14 Common Shares 3375 63075 D Employee Stock Option (Right to Buy) 13.37 2012-08-14 4 A 0 3375 0.00 A 2014-09-30 2022-08-14 Common Shares 3375 66450 D Employee Stock Option (Right to Buy) 13.37 2012-08-14 4 A 0 3375 0.00 A 2015-09-30 2022-08-14 Common Shares 3375 69825 D Employee Stock Option (Right to Buy) 13.37 2012-08-14 4 A 0 3375 0.00 A 2016-09-30 2022-08-14 Common Shares 3375 73200 D Restricted shares granted pursuant to the Invacare Corporation 2003 Performance Plan in an exempt transaction under Rule 16b-3. These shares vest in 25% increments over four years commencing on November 15, 2013. The reporting person holds previously reported options to buy 59,700 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between October 27, 2008 and September 2, 2011, at exercise prices between $16.55 and $25.24 per share, will expire between October 27, 2018 and September 2, 2021 and became or will become exercisable between September 30, 2009 and September 30, 2015. /s/ Anthony C. LaPlaca, by Kristofer K. Spreen, his attorney-in-fact pursuant to Power of Attorney, dated December 30, 2008, on file with the Commission 2012-08-16